Дело T-***/**: *****************, Определение от **.**.2019 г.

Текст

... irachtin — Rejection of the request for confidential treatment — No prima facie case)

In Case T‑675/18 R,

Trifolio-M GmbH, established in Lahnau (Germany),

Oxon Italia SpA, established in Milan (Italy),

Mitsui AgriScience International SA, established in Brussels (Belgium),

represented by C. Mereu and S. Englebert, lawyers,

applicants,

v

European Food Safety Authority (EFSA), represented by D. Detken and S. Gabbi, acting as Agents, assisted by S. Raes, lawyer,

defendant,

Application pursuant to Articles 278 and 279 TFEU seeking the suspension of the operation of the decision of the Executive Director of the European Food Safety Authority on the assessment of the confidentiality claims made in relation to the conclusion on the Peer Review of the pesticide risk assessment of the active substance Azadirachtin of 11 September 2018 (EFSA/LA/DEC/19777743/2018),

THE PRESIDENT OF THE GENERAL COURT

makes the following

Order

Background to the dispute, procedure and forms of order sought by the parties

1. The applicants, Trifolio-M (the ‘first applicant’), Oxon Italia (the ‘second applicant’) and Mitsui AgriScience International (the ‘third applicant’), seek the suspension of the decision of the Executive Director of the European Food Safety Authority (EFSA) on the assessment of the confidentiality claims made in relation to the conclusion on the Peer Review of the pesticide risk assessment of the active substance Azadirachtin (the ‘substance’) of 11 September 2018 (EFSA/LA/DEC/19777743/2018; the ‘contested decision’).

2. The first applicant is a company that markets biological plant protection products based on the substance throughout the EU.

3. The second applicant is ...